Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy

Launched by SAMSUNG MEDICAL CENTER · Mar 25, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the best way to manage breathing during a specific type of surgery called robot-assisted esophagectomy, which is performed to treat esophageal cancer. The researchers want to find out if using a bronchial blocker, a device that helps keep one lung deflated during surgery, can help reduce the risk of vocal cord problems (known as vocal cord palsy) after the operation compared to a double-lumen endobronchial tube, another device used for similar purposes.

To participate in this trial, individuals must be 19 years or older and scheduled for elective robot-assisted esophagectomy due to esophageal cancer. They should be in good health (physical status I-III) and need to have certain lymph nodes removed during their surgery. However, those who already have vocal cord issues, require special breathing devices, have had previous chest surgeries, or are pregnant cannot participate. If you join the trial, you will help researchers understand which method is safer and more effective for patients undergoing this type of surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 19 or older
• • American Society of Anesthesiologists physical status I - III
• • Elective robot-assisted esophagectomy
• • Any clinical stage of esophageal cancer
• • Patients who need recurrent laryngeal nerve lymph nodes resection
• Exclusion Criteria:
• • Patients who diagnosed vocal cord palsy or damage before surgery
• • Patients who need specific airway device due to airway problem
• • History of thoracic surgery
• • Emergency surgery
• • Combined surgery with other department
• • Pregnant or nursing women